Michael H. Ieong MD

Assistant Professor, Pulmonary, Allergy, Sleep & Critical Care Medicine

72 E. Concord Street | (617) 638-4860
michael.ieong@bmc.org
mieong@bu.edu

Sections

Pulmonary, Allergy, Sleep & Critical Care Medicine

Centers

Pulmonary Center

Biography

Dr. Ieong is an Assistant Professor in the Department of Medicine. He attends in the Medical Intensive Care Unit and on the Pulmonary Consult service of Boston Medical Center. He sees patients in the Pulmonary and Allergy outpatient clinic and oversees the cardiopulmonary exercise testing program.

Dr. Ieong's focus is on translational medicine. His research focuses on the innate immunity of the lung in response to infection, particularly in the context of immune compromise such as HIV-infection. His clinical expertise is in critical care medicine and the administration of intensive care units.

Dr. Ieong is a NIH-funded Principal Investigator with research focused on the role of the alveolar macrophage and monocyte in host immunity and HIV-related lung pathogenesis. Projects in the lab study the redox regulation of HIV expression in alveolar macrophages; the role of IL-16 in HIV-infection of alveolar macrophages; and, HIV-induced impairment of alveolar macrophage handling of C. neoformans. He is an experienced research bronchoscopist and collaborates with a number of investigators to provide primary lung cells and lavage for study. He is a member of the Pulmonary Immunology Group and the Center for HIV/AIDS Care and Research.

Research special interests include:
-HIV pathogenesis in the lung
-Redox cell signaling pathways
-Alveolar macrophage biology
-Innate immunity of the lung

Clinical special interests include:
-HIV-related lung disease
-General pulmonary medicine
-Exercise physiology

Websites

BU Profile

Pulmonary, Allergy, Sleep & Critical Care Medicine Faculty

Boston Medical Center Provider Profile

Education

MD, University of Illinois

BA, Oberlin College

Publications

Published on 8/29/2022

Bohula EA, Berg DD, Lopes MS, Connors JM, Babar I, Barnett CF, Chaudhry SP, Chopra A, Ginete W, Ieong MH, Katz JN, Kim EY, Kuder JF, Mazza E, McLean D, Mosier JM, Moskowitz A, Murphy SA, O'Donoghue ML, Park JG, Prasad R, Ruff CT, Shahrour MN, Sinha SS, Wiviott SD, Van Diepen S, Zainea M, Baird-Zars V, Sabatine MS, Morrow DA. Anticoagulation and Antiplatelet Therapy for Prevention of Venous and Arterial Thrombotic Events in Critically Ill Patients With COVID-19: COVID-PACT. Circulation. 2022 Nov; 146(18):1344-1356. PMID: 36036760.

PubMed

Published on 10/1/2021

Bosch NA, Crable EL, Ackerbauer KA, Clark K, Drainoni ML, Grim V, Ieong MH, Walkey AJ, Murphy J. Implementation of a Phenobarbital-based Pathway for Severe Alcohol Withdrawal: A Mixed-Method Study. Ann Am Thorac Soc. 2021 10; 18(10):1708-1716. PMID: 33945771.

PubMed

Published on 10/1/2021

Nadjarian A, LeClair J, Mahoney TF, Awtry EH, Bhatia JS, Caruso LB, Clay A, Greer D, Hingorani KS, Horta LFB, Ibrahim M, Ieong MH, James T, Kulke MH, Lim R, Lowe RC, Moses JM, Murphy J, Nozari A, Patel AD, Silver B, Theodore AC, Wang RS, Weinstein E, Wilson SA, Cervantes-Arslanian AM. Validation of a Crisis Standards of Care Model for Prioritization of Limited Resources During the Coronavirus Disease 2019 Crisis in an Urban, Safety-Net, Academic Medical Center. Crit Care Med. 2021 10 01; 49(10):1739-1748. PMID: 34115635.

PubMed

Published on 9/24/2021

Burgess CM, Batchelder AW, Sloan CA, Ieong M, Streed CG. Impact of the COVID-19 pandemic on transgender and gender diverse health care. Lancet Diabetes Endocrinol. 2021 11; 9(11):729-731. PMID: 34570996.

PubMed

Published on 9/1/2021

Garcia MA, Rampon GL, Doros G, Jia S, Jagan N, Gillmeyer K, Berical A, Hudspeth J, Ieong M, Modzelewski KL, Schechter-Perkins EM, Ross CS, Rucci JM, Simpson S, Walkey AJ, Bosch NA. Rationale and Design of the Awake Prone Position for Early Hypoxemia in COVID-19 Study Protocol: A Clinical Trial. Ann Am Thorac Soc. 2021 09; 18(9):1560-1566. PMID: 33647225.

PubMed

Published on 7/25/2020

Sinha P, Mostaghim A, Bielick CG, McLaughlin A, Hamer DH, Wetzler LM, Bhadelia N, Fagan MA, Linas BP, Assoumou SA, Ieong MH, Lin NH, Cooper ER, Brade KD, White LF, Barlam TF, Sagar M. Early administration of interleukin-6 inhibitors for patients with severe COVID-19 disease is associated with decreased intubation, reduced mortality, and increased discharge. Int J Infect Dis. 2020 Oct; 99:28-33. PMID: 32721528.

PubMed

Published on 8/29/2017

Stephens AR, Wiener RS, Ieong MH. Comparison of Methods To Identify Advance Care Planning in Patients with Severe Chronic Obstructive Pulmonary Disease Exacerbation. J Palliat Med. 2018 03; 21(3):284-289. PMID: 28850288.

PubMed

Published on 6/30/2017

Kozlowski E, Wasserman GA, Morgan M, O'Carroll D, Ramirez NP, Gummuluru S, Rah JY, Gower AC, Ieong M, Quinton LJ, Mizgerd JP, Jones MR. The RNA uridyltransferase Zcchc6 is expressed in macrophages and impacts innate immune responses. PLoS One. 2017; 12(6):e0179797. PMID: 28665939.

PubMed

Published on 9/15/2015

Ozsancak Ugurlu A, Sidhom SS, Khodabandeh A, Ieong M, Mohr C, Lin DY, Buchwald I, Bahhady I, Wengryn J, Maheshwari V, Hill NS. Use and Outcomes of Noninvasive Ventilation for Acute Respiratory Failure in Different Age Groups. Respir Care. 2016 Jan; 61(1):36-43. PMID: 26374908.

PubMed

Published on 7/26/2015

Ozsancak Ugurlu A, Sidhom SS, Khodabandeh A, Ieong M, Mohr C, Lin DY, Buchwald I, Bahhady I, Wengryn J, Maheshwari V, Hill NS. Where is Noninvasive Ventilation Actually Delivered for Acute Respiratory Failure? Lung. 2015 Oct; 193(5):779-88. PMID: 26210474.

PubMed

View full list of 21 publications.